Ripoll L - Search Results

1

Can high plasma ceruloplasmin levels cause acquired activated protein C resistance?

Ripoll L, Mazoyer E, Baudin B, Lacam S, Varsat B, Drouet LO. Ripoll L, et al. Thromb Haemost. 1998 Feb;79(2):449-50. Thromb Haemost. 1998. PMID: 9493610 No abstract available.

2

Multiplex PCR-mediated site-directed mutagenesis for one-step determination of factor V Leiden and G20210A transition of the prothrombin gene.

Ripoll L, Paulin D, Thomas S, Drouet LO. Ripoll L, et al. Thromb Haemost. 1997 Aug;78(2):960-1. Thromb Haemost. 1997. PMID: 9268204 No abstract available.

3

How does ticlopidine treatment lower plasma fibrinogen?

Mazoyer E, Ripoll L, Boisseau MR, Drouet L. Mazoyer E, et al. Among authors: ripoll l. Thromb Res. 1994 Aug 1;75(3):361-70. doi: 10.1016/0049-3848(94)90251-8. Thromb Res. 1994. PMID: 7992249 Review.

4

Different contribution of factor V Leiden-associated hypercoagulability to ischaemic cerebrovascular disease in the elderly.

Ripoll L, Mazoyer E, Woimant F, Drouet LO. Ripoll L, et al. Blood Coagul Fibrinolysis. 1997 Jun;8(4):253-4. doi: 10.1097/00001721-199706000-00009. Blood Coagul Fibrinolysis. 1997. PMID: 9199825 No abstract available.

5

Lack of association between thrombosis in primary antiphospholipid syndrome and the recently described thrombophilic 3'-untranslated prothrombin gene polymorphism.

Bentolila S, Ripoll L, Drouet L, Crassard I, Tournier-Lasserve E, Piette JC. Bentolila S, et al. Among authors: ripoll l. Thromb Haemost. 1997 Nov;78(5):1415. Thromb Haemost. 1997. PMID: 9408029 No abstract available.

6

Plasma gamma'/gamma fibrinogen ratio, a marker of arterial thrombotic activity: a new potential cardiovascular risk factor?

Drouet L, Paolucci F, Pasqualini N, Laprade M, Ripoll L, Mazoyer E, Bal dit Sollier C, Vanhove N. Drouet L, et al. Among authors: ripoll l. Blood Coagul Fibrinolysis. 1999 Feb;10 Suppl 1:S35-9. Blood Coagul Fibrinolysis. 1999. PMID: 10070816 Review. No abstract available.

7

Prevalence of factor V Leiden and prothrombin G20210A mutation in a large French population selected for nonthrombotic history: geographical and age distribution.

Mazoyer E, Ripoll L, Gueguen R, Tiret L, Collet JP, dit Sollier CB, Roussi J, Drouet L; FITENAT Study Group. Mazoyer E, et al. Among authors: ripoll l. Blood Coagul Fibrinolysis. 2009 Oct;20(7):503-10. doi: 10.1097/MBC.0b013e32832f5d7a. Blood Coagul Fibrinolysis. 2009. PMID: 19730248

8

[Targets of antithrombotic drugs].

Drouet L, Ripoll L. Drouet L, et al. Among authors: ripoll l. Med Sci (Paris). 2006 Oct;22(10):887-94. doi: 10.1051/medsci/20062210887. Med Sci (Paris). 2006. PMID: 17026945 Free article. Review. French.

9

[The role of thrombotic and hemostatic mechanisms in the initial phases of atherosclerosis].

Drouet L, Mazoyer E, Bal dit Sollier C, Hainaud P, Ripoll L. Drouet L, et al. Among authors: ripoll l. Arch Mal Coeur Vaiss. 1998 Oct;91 Spec No 5:41-51. Arch Mal Coeur Vaiss. 1998. PMID: 9833079 Review. French.

10

Thrombophilia due to 20210 G-->A prothrombin polymorphism and cerebral ischemia in the young.

Bentolila S, Ripoll L, Drouet L, Mazoyer E, Woimant F. Bentolila S, et al. Among authors: ripoll l. Stroke. 1997 Sep;28(9):1846-7. Stroke. 1997. PMID: 9303036 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54 results

Search Page

Filters